O&
Organon & Co
🇺🇸XNYS.OGNUnited StatesHealthcare
$13.68USDunchanged 0.00 (0%)OpenDelayed6:53 PM
Price$13.680.00 (0%)
Profile
- Healthcare
- Drug Manufacturers - General
- United States
Identity
- Exchange
- New York Stock Exchange . XNYS
- Type
- Stock
- ISIN
- US68622V1061
- CUSIP
- 68622V106
Company
- Employees
- 10,000
- Headquarters
- Jersey City, United States
- Website
- https://www.organon.com
- CEO
- Mr. Joseph T. Morrissey Jr.
Market
- Shares outstanding
- 262.6M
- Market cap
- $3.59B
Key dates
- Next earnings
- Nov 9, 2026
Highlights
- Market cap
- $3.59B
- EPS LTM
- $0.77
- P/E LTM
- 17.47
- Div yield
- 0.49%
Fundamentals (LTM)
- Revenue
- $6.13B-2.45%down year on year
- Net income
- $209M-70.14%down year on year
- Gross margin
- 52.98%-5.84%down year on year
- Free cash flow
- $498M+3.32%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.